Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
Our fourth COVID-19 survey of U.S. diabetes patients highlights persistent concerns, economic stress, and changing behaviors despite easing lockdowns.
Our April 2020 dQ&A survey of 4,700 U.S. diabetes patients finds supply chains largely intact yet short-term delays and risky pharmacy visits hinder refills.
